Drug intelligence / Profile preview

Zhengzhou Univ. LSD1 compound 7d

Development stage: Unknown
Lead developer: Zhengzhou University

Overview

Zhengzhou Univ. LSD1 compound 7d: sourced facts only. name: "In summary, the current report presents compound 7d as a potent LSD1 inhibitor with the potential for further development as a therapeutic agent for pressure overload-related heart failure." [PMID:39036880]; target: "In summary, the current report presents compound 7d as a potent LSD1 inhibitor with the potential for further development as a therapeutic agent for pressure overload-related heart failure." [PMID:39036880]; developer: "College of Chemistry, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, P.R. China." [PMID:39036880]

Targets

KDM1A (LSD1)

Beyond the preview

Go deeper on Zhengzhou Univ. LSD1 compound 7d.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhengzhou Univ. LSD1 compound 7d.